共 50 条
- [1] Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause Advances in Therapy, 2024, 41 : 1885 - 1895
- [3] Prevalence and impact of vasomotor symptoms due to menopause: Canadian subgroup of the Women with Vasomotor Symptoms Associated With Menopause (WARM) study MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1305 - 1305
- [5] Incremental direct and indirect costs of untreated vasomotor symptoms MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (03): : 260 - 266
- [7] Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (16): : 1343 - 1354
- [9] Global Prospective Survey of Women with Vasomotor Symptoms Associated with Menopause: US Findings MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1459 - 1459
- [10] Desvenlafaxine succinate (DVS) does not cause significant weight gain in women treated for vasomotor symptoms (VMS) associated with menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1094 - 1094